We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$14.6B
AUM Growth
-$1.84B
Cap. Flow
-$1.86B
Cap. Flow %
-12.78%
Top 10 Hldgs %
34.48%
Holding
2,201
New
633
Increased
437
Reduced
361
Closed
764

Top Buys

Rank Stock Value
1
DUK icon
Duke Energy
DUK
+$172M
2
CVX icon
Chevron
CVX
+$99.4M
3
AAPL icon
Apple
AAPL
+$91.7M
4
EVRG icon
Evergy
EVRG
+$89M
5
ED icon
Consolidated Edison
ED
+$86.6M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$412M
2
MDLZ icon
Mondelez International
MDLZ
+$131M
3
JNJ icon
Johnson & Johnson
JNJ
+$107M
4
NI icon
NiSource
NI
+$88.5M
5
PPL
PPL Corp
PPL
+$86.4M

Sector Composition

Rank Sector Weight
1 Financials 9.81%
2 Technology 9.77%
3 Healthcare 7.98%
4 Utilities 7.37%
5 Real Estate 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FULT icon
726
Fulton Financial
FULT
$4.51B
$1.9M 0.01%
98,436
-125,022
-56% -$2.45M
GOLD
727
Gold.com Inc
GOLD
$1.34B
$1.9M 0.01%
69,207
+50,580
+272% +$1.72M
CHTR icon
728
Charter Communications
CHTR
$17.9B
$1.89M 0.01%
5,525
-7,381
-57% -$2.67M
AFG icon
729
American Financial Group
AFG
$11.9B
$1.89M 0.01%
+13,826
New +$1.9M
BHE icon
730
Benchmark Electronics
BHE
$2.61B
$1.89M 0.01%
+41,706
New +$1.94M
SNEX icon
731
StoneX
SNEX
$8.26B
$1.89M 0.01%
+65,219
New +$1.83M
SLAB icon
732
Silicon Laboratories
SLAB
$7.27B
$1.89M 0.01%
+15,224
New +$1.75M
SLVM icon
733
Sylvamo
SLVM
$1.46B
$1.89M 0.01%
+23,925
New +$2.06M
MAX icon
734
MediaAlpha
MAX
$793M
$1.88M 0.01%
166,912
+145,271
+671% +$2.09M
CRSP icon
735
CRISPR Therapeutics
CRSP
$5.75B
$1.88M 0.01%
+47,840
New +$2.26M
RL icon
736
Ralph Lauren
RL
$22.2B
$1.88M 0.01%
+8,151
New +$1.74M
CLF icon
737
CALL
Cleveland-Cliffs
CLF
$6.43B
$1.88M 0.01%
+200,000
New +$2.41M
TDAY
738
USA Today Co
TDAY
$950M
$1.88M 0.01%
370,875
+341,598
+1,167% +$1.81M
MXL icon
739
MaxLinear
MXL
$6.04B
$1.86M 0.01%
+93,982
New +$1.51M
AMRC icon
740
Ameresco
AMRC
$1.13B
$1.85M 0.01%
+78,752
New +$2.27M
DLX icon
741
Deluxe
DLX
$1.08B
$1.85M 0.01%
81,863
+15,827
+24% +$340K
QCOM icon
742
CALL
Qualcomm
QCOM
$169B
$1.84M 0.01%
12,000
+9,400
+362% +$1.54M
SHEN icon
743
Shenandoah Telecom
SHEN
$683M
$1.83M 0.01%
145,450
-12,831
-8% -$173K
APH icon
744
Amphenol
APH
$194B
$1.83M 0.01%
+26,345
New +$1.84M
DELL icon
745
Dell
DELL
$286B
$1.83M 0.01%
+15,867
New +$1.99M
ENVA icon
746
Enova International
ENVA
$6.05B
$1.83M 0.01%
19,080
+8,428
+79% +$803K
PLGO
747
Pelagos Insurance Capital
PLGO
$2.06B
$1.83M 0.01%
100,869
+38,175
+61% +$709K
TWST icon
748
Twist Bioscience
TWST
$9.13B
$1.83M 0.01%
+39,300
New +$1.78M
MHO icon
749
M/I Homes
MHO
$3.85B
$1.81M 0.01%
13,646
+4,453
+48% +$701K
COLL icon
750
Collegium Pharmaceutical
COLL
$840M
$1.81M 0.01%
63,239
-4,213
-6% -$139K

Similar funds

Michael Gelband's Q4 2024 Portfolio in Review

As of Q4 2024, Michael Gelband held 2,201 positions worth $14.6B, down 11% from $16.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Michael Gelband withdrew a net $1.86B in Q4 2024, closing 764 positions and reducing 361 holdings. Its most notable exit was Mondelez International, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.8% of assets, up from 4.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Michael Gelband opened a new position in Duke Energy worth $164M.

  • Michael Gelband's largest Q4 2024 buy was Duke Energy: 1,520,504 shares worth $164M.
  • Michael Gelband added most to Chevron in Q4 2024, an estimated $99.4M increase.
  • Michael Gelband's biggest Q4 2024 reduction was Microsoft, cutting an estimated $412M.
  • Michael Gelband fully exited Mondelez International in Q4 2024, selling an estimated $131M.
  • Michael Gelband's ten largest holdings make up 34% of its $14.6B portfolio in Q4 2024.
  • Michael Gelband opened 633 new positions and closed 764 in Q4 2024.
  • Michael Gelband's portfolio value fell 11% quarter-over-quarter to $14.6B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.